Federal agriculture officials will delay the requirement that all THC testing on hemp crops must be performed at laboratories registered with the U.S. Drug Enforcement Administration.
And food and drug regulators say it’s a “fool’s errand” to get people to stop taking over-the-counter CBD.
The testing delay comes after farmers and states alike complained there wouldn’t be enough DEA labs to handle demand. The U.S. Department of Agriculture acknowledges the complaints in an update Thursday.
“We now better understand how the limited number of DEA-registered labs will hinder testing and better understand the associated costs with disposing of product that contains over 0.3% THC could make entering the hemp market too risky,” USDA wrote.
“We were able to reach an agreement (with DEA) that we are going to be able to provide some relief from the laboratory certification process for this crop year,” Greg Ibach, undersecretary for the U.S. Department of Agriculture, told members at the National Association of State Departments of Agriculture (NASDA) meeting this week in Arlington, Virginia.
“DEA will still expect states to work with their laboratories to try to achieve certification for the 2021 crop year,” he added.
Published February 26, 2020 | By Laura Drotleff